We already demonstrated the feasibility of the approach of using lipoplexes to obtain the inhibition of the C1858T allelic variant of PTPN22 in T1D peripheral blood mononuclear cells (PBMCs) [12]. Here, PTPN22 is linked to type 1 diabetes mellitus.